| Popis: |
Purpose PET imaging using [11C]metoclopramide revealed the importance of P-glycoprotein (P-gp, ABCB1) in mediating the brain-to-blood efflux of substrates across the blood-brain barrier (BBB). In this work, the elimination rate constant from the brain (kE,brain), calculated from dynamic PET images without the need for arterial blood sampling, was evaluated as an outcome parameter for the interpretation of [11C]metoclopramide PET data. Procedures: k E,brain parameter was obtained by linear regression of log-transformed brain time-activity curves (TACs). kE,brain values (h− 1) obtained under baseline conditions were compared with values obtained after complete P-gp inhibition using tariquidar in rats (n = 4) and baboons (n = 4) or after partial inhibition using cyclosporine A in humans (n = 10). In baboons, the sensitivity of kE,brain to measure complete P-gp inhibition was compared with outcome parameters derived from kinetic modeling using a 1-tissue compartment model (1-TCM). Finally, kE,brain-maps were generated in each species using PMOD software. Results The The linear part of the log-transformed brain TACs occurred from 10–30 min after radiotracer injection in rats, from 15–60 min in baboons and from 20–60 min in humans. P-gp inhibition significantly decreased kE,brain values by 39 ± 12% in rats (p k2 (36 ± 9%, p VT, 101 ± 12%, p kE,brain-maps displayed decreased P-gp-mediated efflux across the BBB. Conclusions k E,brain of [11C]metoclopramide provides a simple outcome parameter to describe P-gp function in the living brain when arterial input function data are unavailable, although less sensitive than VT. kE,brain-maps represent easy to compute parametric images reflecting the effect of P-gp on [11C]metoclopramide elimination from the brain. |
